acetyl-aspartyl-glutamyl-valyl-aspartal has been researched along with cupric-nitrilotriacetate* in 1 studies
1 other study(ies) available for acetyl-aspartyl-glutamyl-valyl-aspartal and cupric-nitrilotriacetate
Article | Year |
---|---|
Cupric nitrilotriacetate-induced apoptosis in HL-60 cells association with lipid peroxidation, release of cytochrome C from mitochondria, and activation of caspase-3.
Oxidative stress may be a common mechanism underlying various forms of cell death, including necrosis and apoptosis. The authors have reported previously that the cupric nitrilotriacetate (Cu-NTA), a renal carcinogen, induces oxidative DNA damage and apoptosis in HL-60 human leukemia cells (Ma, Y., et al. Free Radic. Biol Med. 25:568-575; 1998). The focus of this investigation was to examine the possible pathway of the apoptosis induced by Cu-NTA. Results of the present study demonstrated that after exposure of HL-60 cells to Cu-NTA, an increase in lipid hydroperoxide and loss of mitochondrial membrane potential (deltaphim) were observed, followed by the increase in cytosolic cytochrome c that was released from the mitochondria. These events proceeded and triggered the activation of caspase-3 (CPP32/apopain/Yama), resulting in the degradation of poly (ADP-ribose) polymerase and DNA fragmentation. The antioxidants, N-acetylcysteine and glutathione, protected the loss of deltaphim and blocked the apoptosis induced by Cu-NTA. In addition, Ac-DEVD-CHO, a specific inhibitor of caspase-3, inhibited Cu-NTA-induced apoptosis. These results suggested that Cu-NTA-induced apoptosis in HL-60 cells was, at least in part, triggered by free radical-induced lipid peroxidation of membrane, which induced the release of cytochrome c from mitochondria and activation of caspase-3. Topics: Acetylcysteine; Antioxidants; Apoptosis; Caspase 3; Caspase Inhibitors; Caspases; Copper; Cysteine Proteinase Inhibitors; Cytochrome c Group; Dimethyl Sulfoxide; Enzyme Activation; Glutathione; HL-60 Cells; Humans; Lipid Peroxidation; Mitochondria; Nitrilotriacetic Acid; Oligopeptides; Organometallic Compounds | 1999 |